219
Participants
Start Date
June 30, 2011
Primary Completion Date
March 31, 2015
Study Completion Date
October 31, 2015
Gefitinib
Gefitinib 250mg/d every cycle d15-25,and Gefitinib 250mg/d from d15 of last cycle until disease progression
Gemcitabine +Carboplatin
Gemcitabine 1250mg/m2+Carboplatin AUC=5, every 4 weeks, maximum 4 cycles
Shanghai Lung Tumor Clinical Center,Shanghai Chest Hospital, Shanghai
The First Hospital of Jilin University
OTHER
Ruijin Hospital
OTHER
Fudan University
OTHER
Jiangsu Cancer Institute & Hospital
OTHER
Nanjing PLA General Hospital
OTHER
Wuxi No. 4 People's Hospital
OTHER
The First Affiliated Hospital of Soochow University
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Sir Run Run Shaw Hospital
OTHER
Henan Cancer Hospital
OTHER_GOV
Changhai Hospital
OTHER
NanJing PLA 81 Hospital
OTHER
First People's Hospital of Hangzhou
OTHER
Guangdong Association of Clinical Trials
OTHER